CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
CareDx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$67.08+3.08 (+4.81%)
Close on Oct 19, 2026
- Market cap
- $3.58B
- P/E (TTM)
- 32.4
- Dividend yield
- –
CareDx, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $379.81M | $333.79M | $280.32M | $321.79M | – | – | – | – | – | – | 100.0% | +13.8% |
| CareDx [Member] | – | – | – | – | – | – | – | – | – | $29.92M | – | – |
| Olerup [Member] | – | – | – | – | – | – | – | – | – | $10.71M | – | – |
| Former Post-Transplant [Member] | – | – | – | – | – | – | – | – | $33.69M | $29.92M | – | – |
| Pre-Transplant [Member] | – | – | – | – | – | – | – | – | $14.63M | $10.72M | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CareDx [Member] | – | – | – | – | – | – | – | – | – | -$18.37M | – |
| Olerup [Member] | – | – | – | – | – | – | – | – | – | -$18.96M | – |
| Former Post-Transplant [Member] | – | – | – | – | – | – | – | – | -$14.33M | -$18.37M | – |
| Pre-Transplant [Member] | – | – | – | – | – | – | – | – | -$5.96M | -$18.96M | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Testing services revenue | $274.50M | $249.38M | $209.69M | $263.75M | $259.29M | $163.61M | $104.55M | $60.30M | $33.11M | $29.68M | 72.3% | +10.1% |
| Patient and digital solutions revenue | $56.93M | $43.62M | $37.12M | $28.79M | $10.28M | $9.28M | $4.24M | – | – | – | 15.0% | +30.5% |
| Product revenue | $48.38M | $40.78M | $33.52M | $29.25M | $26.83M | $19.30M | $18.28M | $15.67M | $14.63M | $10.72M | 12.7% | +18.6% |
| Digital and other revenue | – | – | – | – | – | $9.28M | $4.24M | $595.00K | $584.00K | $236.00K | – | – |
| Royalty [Member] | – | – | – | – | – | – | – | $300.00K | $500.00K | $200.00K | – | – |
| Digital and other revenue | – | – | – | – | – | $9.28M | $4.24M | $595.00K | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $359.94M | $317.73M | $265.63M | $307.54M | $282.01M | $181.50M | $116.20M | $66.06M | $37.29M | $32.69M | 94.8% | +13.3% |
| Rest of World | $19.87M | $16.05M | $14.69M | – | – | – | – | – | – | – | 5.2% | +23.8% |
| Europe, Middle East and Africa [Member] | – | – | – | – | – | – | – | – | – | $6.99M | – | – |
| North America [Member] | – | – | – | – | – | – | – | – | $38.20M | $33.22M | – | – |
| Latin America [Member] | – | – | – | – | – | – | – | – | – | $424.00K | – | – |
| Australia | – | – | – | – | – | – | – | – | $411.00K | $0 | – | – |
| Rest of World | – | – | – | – | – | – | – | – | $1.73M | $1.15M | – | – |
| Europe | – | $10.67M | $10.17M | $9.55M | $9.82M | $7.56M | $7.79M | $7.60M | $8.07M | $6.31M | – | – |
| Rest of World | – | $5.38M | $4.53M | $4.70M | $4.57M | $3.13M | $3.08M | $2.90M | $2.97M | $1.63M | – | – |
From the segment and revenue-disaggregation notes of CareDx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.